Day

October 21, 2019
Key Points Biologics are large molecule products, such as proteins or monoclonal antibodies, with inherent variations that make them impossible to replicate. Biosimilars are defined by the FDA as “biological products that are highly similar to and have no clinically meaningful differences from an existing FDA-approved reference product.” An interchangeable product is defined by the...
Read More